OpenEvidence - About the company
OpenEvidence is a series D company based in Miami (United States), founded in 2021 by Daniel Nadler and Zachary Ziegler. It operates as an AI powered medical search platform for healthcare professionals. OpenEvidence has raised $735M in funding from investors like Google Ventures, Sequoia Capital and Thrive Capital, with a current valuation of $6B. The company has 141 active competitors, including 11 funded and 9 that have exited. Its top competitors include companies like Nested Knowledge, iDoctus and Dawaey.
Sectors and market segments that OpenEvidence operate in
OpenEvidence serves in the HealthTech, Native AI market segments.The primary business model of OpenEvidence are:Company Details
AI powered medical search platform for healthcare professionals. It aggregates, synthesizes, and visualizes clinically relevant evidence in a format. It aims to provide healthcare professionals with accurate and access to medical information, supporting informed decision making in clinical practice. It provides solutions to enhance the accessibility and usability of peer reviewed medical literature for healthcare professionals.
- Website
- www.openevidence.com/
- Email ID
- *****@openevidence.com
- Registered Address
- San Francisco , California 94065, US
Key Metrics
Founded Year
2021
Location
Miami, United States
Stage
Series D
Total Funding
$735M in 11 rounds
Latest Funding Round
Post Money Valuation
$6B as on Oct 20, 2025
Investors
Ranked
1st among 141 active competitors
Employee Count
119 as on May 31, 2026
Investment & Acquisitions
Similar Companies
Legal entities associated with OpenEvidence
OpenEvidence is associated with 1 legal entity given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
OPENEVIDENCE INC. CIN: 7540731 , United States, Active | Jul 31, 2019 | - | - | - |
Sign up to download OpenEvidence's company profile
OpenEvidence's funding and investors
OpenEvidence has raised a total funding of $735M over 11 rounds. Its first funding round was on Jan 01, 2015. Its latest funding round was a Series D round on Jan 21, 2026 for $250M. 19 investors participated in its latest round. OpenEvidence has 22 institutional investors and 1 angel investor.
Here is the list of recent funding rounds of OpenEvidence:
Filter this list
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Jan 21, 2026 | $250M | Series D | - | - | ||
Oct 20, 2025 | $200M | Series C | $6B | - | ||
Jul 15, 2025 | $210M | Series B | $3.5B | - |
View details of OpenEvidence's funding rounds and investors
OpenEvidence's founders and board of directors
Founder? Claim ProfileThe founders of OpenEvidence are Daniel Nadler and Zachary Ziegler.
Here are the details of OpenEvidence's key team members:
- Daniel Nadler: Co-Founder of OpenEvidence and founder of 1 other company. They are also an angel investor in 3 startups and serve on the board of 1 company.Contact Info: 2 email addresses
- Zachary Ziegler: Co-Founder & CTO of OpenEvidence. Contact Info: 1 email address
View details of OpenEvidence's Founder profiles and Board Members
OpenEvidence's employee count trend
OpenEvidence has 119 employees as of May 26. Here is OpenEvidence's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
OpenEvidence's Competitors and alternates
Top competitors of OpenEvidence include Nested Knowledge, iDoctus and Dawaey. Here is the list of Top 10 competitors of OpenEvidence, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | OpenEvidence 2021, Miami (United States), Series D | AI powered medical search platform for healthcare professionals | $735M | 78/100 | |
2nd | Nested Knowledge 2018, Saint Paul (United States), Series A | Provider of a clinical evidence platform for pharma, device, and research entities | $6.76M | 58/100 | |
3rd | iDoctus 2011, Spain (United States), Unfunded | Provider of learning platform for medical professionals | - | - | 54/100 |
4th | Provider of an AI-based app for drug search for healthcare providers | - | - | 43/100 | |
5th | Bulletin Healthcare 2010, Reston (United States), Unfunded | Platform for providing email briefings | - | - | 42/100 |
6th | DynaMed 2019, Ipswich (United States), Unfunded | Information provider for diseases | - | - | 41/100 |
7th | Clinical resource platform for healthcare professionals | - | - | 41/100 | |
8th | Mobile medical apps for healthcare professionals | - | - | 41/100 | |
9th | thumbroll 2011, Los Angeles (United States), Unfunded | Provider of app for education for medical trainee and professionals. | - | - | 40/100 |
10th | ![]() Makindo 2024, United Kingdom, Unfunded | Provides fo medical encyclopedia and educational resource for medical professionals | - | - | 40/100 |
Looking for more details on OpenEvidence's competitors? Click here to see the top ones
OpenEvidence's Investments and acquisitions
OpenEvidence has acquired Amaro. OpenEvidence has not made any investments as of now.Reports related to OpenEvidence
Here is the latest report on OpenEvidence's sector:
News related to OpenEvidence
Media has covered OpenEvidence for a total of 31 events in the last 1 year, 11 of them have been about partnerships and 9 about company updates.
•
SNO and OpenEvidence Launch Official Generative AI PartnershipBusiness Wire•Jun 23, 2026•OpenEvidence
•
OpenEvidence Integrates ASCO Guidelines, Figures and Flowcharts into Specialty Oncology ModelBusiness Wire•May 27, 2026•OpenEvidence
•
OpenEvidence Launches Hands-Free Medical AI for 860,000 CliniciansPYMNTS.com•May 21, 2026•OpenEvidence
•
OpenEvidence Launches Voice Mode: The First Native Speech-to-Speech Medical AIBusiness Wire•May 21, 2026•OpenEvidence
•
•
•
•
OpenEvidence and ACOG Announce Strategic Collaboration to Advance Ob-Gyn Health CareBusiness Wire•May 04, 2026•ACOG, OpenEvidence
•
•
OpenEvidence Introduces Dotflows: AI-Native Customization For Every ClinicianBusiness Wire•Apr 07, 2026•OpenEvidence
Are you a Founder ?
FAQs about OpenEvidence
Explore our recently published companies
- Biene Electronics - Riga based, 1992 founded, Unfunded company
- CrossChip MicroSystems - Chengdu based, 2013 founded, Series A company
- Ningbo RaySea Technology - Hangzhou based, 2017 founded, Series A company
- [Smt Pcb Assembly] - Unfunded company
- Peeti Securities Limited - Hyderabad based, Public company
- Voxpark - Germany based, Unfunded company
